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Background: Trimethylamine-N-oxide (TMAO), a gut microbiota metabolite from dietary of phosphatidylcholine, shows a mechanistic link 
to coronary artery disease (CAD) pathogenesis and adverse outcomes. We aimed to examine the relationship between fasting plasma 
TMAO levels and the complexity and burden of CAD.
methods: We studies 303 consecutive patients with evidence of significance CAD based on elective coronary angiography between 2012-
4. The SYNTAX score was used to quantify atherosclerosis burden, and fasting plasma TMAO was measured by mass spectrometry.
results: In our study cohort (mean age 64±11 years, 79% men), median TMAO was 5.6 μΜ (Interquartile range [IQR] 3.5-10.0 μΜ), 
median SYNTAX score was 11.0 (IQR 4.0-18.5), and 250 (82.5%), 34 (11.2%) and 19 (6.3%) had low (score=0-22), intermediate 
(score=23-32), and high (score=≥33) SYNTAX score, respectively. Higher SYNTAX score was more likely to be older, with hypertension, 
and with diabetes. Plasma TMAO levels correlated with SYNTAX score (r=0.56; p<0.001, Figure). Following ordinal regression analysis 
adjusting for traditional risk factors, elevated TMAO levels remained independently associated with higher SYNTAX score (adjusted odds 
ratio 3.25 (95%CI 2.00-5.28, p<0.001).
Conclusion:  Fasting plasma TMAO levels is an independent predictor for high atherosclerosis burden in patients with CAD.
 
